A cross-sectional analysis of variation in charges and prices across California for percutaneous coronary

Renee Y Hsia1, Yaa Akosa Antwi2, Ellerie Weber3

  • 1Department of Emergency Medicine, University of California San Francisco, San Francisco, California, United States of America.

Plos One
|August 5, 2014
PubMed

Insights

Hospital charges for percutaneous coronary intervention (PCI) vary significantly, with factors like location and ownership influencing costs. Most price variation remains unexplained by hospital characteristics.

Area of Science:

  • Health Economics
  • Healthcare Management
  • Cardiovascular Interventions

Background:

  • Previous research indicates significant variation in hospital pricing for procedures.
  • However, limited data exists on price discrepancies for specific, common care episodes.

Purpose of the Study:

  • To analyze price variations for drug-eluting stent percutaneous coronary intervention (PCI) without complications (MS-DRG-247).
  • To identify hospital and market factors influencing these PCI charges.

Main Methods:

  • Cross-sectional analysis of California hospital discharge data (2011) for MS-DRG-247.
  • Two-part linear regression to adjust for patient characteristics and assess influence of hospital/market factors.

Main Results:

  • Uncomplicated PCI charges ranged from $22,047 to $165,386 (median $88,350).
  • Higher charges correlated with high cost-of-living areas, rural locations, and more Medicare patients; government hospitals charged less.
  • Model explained 43% of charge variation; estimated private insurer prices ranged from $3,421 to $80,903 (median $28,571).

Conclusions:

  • Significant hospital price variation exists for uncomplicated PCI, a standardized care episode.
  • Observable hospital characteristics explain only a portion of the wide price discrepancies.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.3K